Well, for 1 thing, they are on the NASDAQ and we are on OTC. Second, they actually say they have a vaccine to start inoculating in India. We still need to show our final epitope and start trials. Also they were $0.29 back on 12/9, so we could move up fast if our management gets the right news out there and moving forward.
(3)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.